These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7396451)

  • 61. Emergence of ciprofloxacin resistance in nosocomial methicillin-resistant Staphylococcus aureus isolates. Resistance during ciprofloxacin plus rifampin therapy for methicillin-resistant S aureus colonization.
    Peterson LR; Quick JN; Jensen B; Homann S; Johnson S; Tenquist J; Shanholtzer C; Petzel RA; Sinn L; Gerding DN
    Arch Intern Med; 1990 Oct; 150(10):2151-5. PubMed ID: 2222100
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis.
    Lowy FD; Wexler MA; Steigbigel NH
    J Lab Clin Med; 1982 Jul; 100(1):94-104. PubMed ID: 6919570
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficacy of a novel rifamycin derivative, ABI-0043, against Staphylococcus aureus in an experimental model of foreign-body infection.
    Trampuz A; Murphy CK; Rothstein DM; Widmer AF; Landmann R; Zimmerli W
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2540-5. PubMed ID: 17502404
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection.
    Schrenzel J; Harbarth S; Schockmel G; Genné D; Bregenzer T; Flueckiger U; Petignat C; Jacobs F; Francioli P; Zimmerli W; Lew DP;
    Clin Infect Dis; 2004 Nov; 39(9):1285-92. PubMed ID: 15494904
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment of Staphylococcus aureus-induced chronic osteomyelitis with bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres.
    Yan L; Jiang DM; Cao ZD; Wu J; Wang X; Wang ZL; Li YJ; Yi YF
    Drug Des Devel Ther; 2015; 9():3665-76. PubMed ID: 26213463
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci.
    Ramos MC; Ing M; Kim E; Witt MD; Bayer AS
    Antimicrob Agents Chemother; 1996 Jan; 40(1):97-101. PubMed ID: 8787887
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Therapy for experimental endocarditis due to Staphylococcus epidermidis.
    Kobasa WD; Kaye KL; Shapiro T; Kaye D
    Rev Infect Dis; 1983; 5 Suppl 3():S533-7. PubMed ID: 6635444
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
    Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
    J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy of linezolid plus rifampin in an experimental model of methicillin-susceptible Staphylococcus aureus endocarditis.
    Dailey CF; Pagano PJ; Buchanan LV; Paquette JA; Haas JV; Gibson JK
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2655-8. PubMed ID: 12878535
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparative evaluation of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits.
    Mader JT; Adams K
    Antimicrob Agents Chemother; 1989 May; 33(5):689-92. PubMed ID: 2546488
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
    Galetto DW; Boscia JA; Kobasa WD; Kaye D
    J Infect Dis; 1986 Jul; 154(1):69-75. PubMed ID: 2940303
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Treatment of CSF shunt infections with intrashunt plus oral antibiotic therapy.
    Frame PT; McLaurin RL
    J Neurosurg; 1984 Feb; 60(2):354-60. PubMed ID: 6607326
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Short-course and single-dose antimicrobial therapy for chancroid in Kenya: studies with rifampin alone and in combination with trimethoprim.
    Plummer FA; Nsanze H; D'Costa LJ; Ndugga Maggwa AB; Girouard Y; Karasira P; Albritton WL; Ronald AR
    Rev Infect Dis; 1983; 5 Suppl 3():S565-72. PubMed ID: 6635447
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prosthetic valve endocarditis due to methicillin-resistant Staphylococcus epidermidis and Micrococcus species successfully treated with rifampicin combined with other antibiotics.
    Colebunders R; Ursi JP; Pattyn S; Snoeck J
    J Infect; 1985 Jul; 11(1):35-9. PubMed ID: 3875661
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of staphylococcal biofilm.
    El Haj C; Murillo O; Ribera A; Lloberas N; Gómez-Junyent J; Tubau F; Fontova P; Cabellos C; Ariza J
    Int J Antimicrob Agents; 2018 Jun; 51(6):854-861. PubMed ID: 29374577
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Rifampin in experimental endocarditis due to Staphylococcus aureus in rabbits.
    Zak O; Scheld WM; Sande MA
    Rev Infect Dis; 1983; 5 Suppl 3():S481-90. PubMed ID: 6635437
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Errors in the laboratory assessment of rifampicin-trimethoprin combinations for clinical use.
    Brumfitt W; Hamilton-Miller JM
    J Antimicrob Chemother; 1979 May; 5(3):311-5. PubMed ID: 479066
    [No Abstract]   [Full Text] [Related]  

  • 78. Study on rifampicin. I. Penetration into the bone in man after single dose of 750 mg.
    Vacek V; Hejzlar M; Pavlansky R
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):217-9. PubMed ID: 4917426
    [No Abstract]   [Full Text] [Related]  

  • 79. Intracellular Staphylococcus aureus and antibiotic resistance: implications for treatment of staphylococcal osteomyelitis.
    Ellington JK; Harris M; Hudson MC; Vishin S; Webb LX; Sherertz R
    J Orthop Res; 2006 Jan; 24(1):87-93. PubMed ID: 16419973
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Combination of quinupristin-dalfopristin (Synercid) and rifampin is highly synergistic in experimental Staphylococcus aureus joint prosthesis infection.
    Saleh-Mghir A; Ameur N; Muller-Serieys C; Ismael F; Lemaitre F; Massias L; Feger C; Bléton R; Crémieux AC
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1122-4. PubMed ID: 11897604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.